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Stimulation of TLR3 Triggers Release of Lysosomal ATP in Astrocytes and
Epithelial Cells That Requires TRPML1 Channels
Abstract
Cross-reactions between innate immunity, lysosomal function, and purinergic pathways may link signaling
systems in cellular pathologies. We found activation of toll-like receptor 3 (TLR3) triggers lysosomal ATP
release from both astrocytes and retinal pigmented epithelial (RPE) cells. ATP efflux was accompanied by
lysosomal acid phosphatase and beta hexosaminidase release. Poly(I:C) alkalinized lysosomes, and
lysosomal alkalization with bafilomycin or chloroquine triggered ATP release. Lysosomal rupture with
glycyl-L-phenylalanine-2-naphthylamide (GPN) eliminated both ATP and acid phosphatase release.
Secretory lysosome marker LAMP3 colocalized with VNUT, while MANT-ATP colocalized with
LysoTracker. Unmodified membrane-impermeant 21-nt and "non-targeting" scrambled 21-nt siRNA
triggered ATP and acid phosphatase release, while smaller 16-nt RNA was ineffective. Poly(I:C)dependent ATP release was reduced by TBK-1 block and in TRPML1-/- cells, while TRPML activation with
ML-SA1 was sufficient to release both ATP and acid phosphatase. The ability of poly(I:C) to raise
cytoplasmic Ca2+ was abolished by removing extracellular ATP with apyrase, suggesting ATP release by
poly(I:C) increased cellular signaling. Starvation but not rapamycin prevented lysosomal ATP release. In
summary, stimulation of TLR3 triggers lysosomal alkalization and release of lysosomal ATP through
activation of TRPML1; this links innate immunity to purinergic signaling via lysosomal physiology, and
suggests even scrambled siRNA can influence these pathways. © 2018 The Author(s).
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Stimulation of TLR3 triggers release
of lysosomal ATP in astrocytes
and epithelial cells that requires
TRPML1 channels
Jonathan M. Beckel 1,6, Néstor Más Gómez1, Wennan Lu1, Keith E. Campagno1, Bardia Nabet1,
Farraj Albalawi1,3, Jason C. Lim1, Kathleen Boesze-Battaglia2 & Claire H. Mitchell1,4,5
Cross-reactions between innate immunity, lysosomal function, and purinergic pathways may link
signaling systems in cellular pathologies. We found activation of toll-like receptor 3 (TLR3) triggers
lysosomal ATP release from both astrocytes and retinal pigmented epithelial (RPE) cells. ATP efflux was
accompanied by lysosomal acid phosphatase and beta hexosaminidase release. Poly(I:C) alkalinized
lysosomes, and lysosomal alkalization with bafilomycin or chloroquine triggered ATP release.
Lysosomal rupture with glycyl-L-phenylalanine-2-naphthylamide (GPN) eliminated both ATP and
acid phosphatase release. Secretory lysosome marker LAMP3 colocalized with VNUT, while MANTATP colocalized with LysoTracker. Unmodified membrane-impermeant 21-nt and “non-targeting”
scrambled 21-nt siRNA triggered ATP and acid phosphatase release, while smaller 16-nt RNA was
ineffective. Poly(I:C)-dependent ATP release was reduced by TBK-1 block and in TRPML1−/− cells,
while TRPML activation with ML-SA1 was sufficient to release both ATP and acid phosphatase. The
ability of poly(I:C) to raise cytoplasmic Ca2+ was abolished by removing extracellular ATP with apyrase,
suggesting ATP release by poly(I:C) increased cellular signaling. Starvation but not rapamycin prevented
lysosomal ATP release. In summary, stimulation of TLR3 triggers lysosomal alkalization and release
of lysosomal ATP through activation of TRPML1; this links innate immunity to purinergic signaling via
lysosomal physiology, and suggests even scrambled siRNA can influence these pathways.
Purinergic signaling involves a complex set of receptors whose activation is controlled by tight spatial and temporal regulation of ATP release. Stimuli such as mechanical stretch1–3, chemical stimulation4, membrane depolarization5, pathogen binding6 or hypoxia7 can cause the release of ATP from cells. Cellular mechanisms responsible
for this release of ATP also vary widely. For example, ATP can be released through large-pore ion channels such
as pannexins, calcium homeostasis (CALHM) channels or voltage gated anion channels (VDACs)8–11. ATP is
released from neurons using traditional synaptic processes, where ATP is stored in and released from vesicles
that fuse with the plasma membrane12–14. Astrocytes and other cell types also release ATP through vesicular
methods15–18. Lysosomes are an important source of vesicular ATP release from non-neural cells, with the fusion
of lysosomal and plasma membranes leading to ATP exocytosis19–21.
The lysosome is emerging as a central organizing hub within the cell, coordinating several pathways including
autophagy, energetics and signaling22. Lysosomes also participate in defense against invading pathogens through
Toll-like receptors (TLRs), leading to phagocytosis of pathogens, maturation of phagosomes by binding with lysosomes, and activation of inflammatory responses23. The TLR3 receptor is particularly relevant for the lysosome,
with activation triggered by dsRNA from viruses as well as some synthetic RNA molecules24,25. While purinergic
signaling plays a key role in host-pathogen interactions26, the contribution of lysosomal ATP release is unknown.
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We asked whether stimulation of TLR3s led to release of lysosomal ATP. Our results suggest that stimulation
of TLR3 triggers lysosomal alkalization and release of ATP and lysosomal contents from both optic nerve head
astrocytes (ONHA) and retinal pigmented epithelial (RPE) cells. Moreover, we demonstrate that 21-nt siRNA, but
not 16-nt siRNA, also activates lysosomal ATP release, indicating that commercially available siRNA molecules
may trigger this response.

Results

TLR3 stimulation triggers release of ATP and lysosomal markers from RPE cells.

Initial experiments were performed using the human ARPE-19 cell line. Exposure of these cells to 10 µg/ml of the TLR3 agonist poly(I:C) for 20 min increased extracellular levels of ATP bathing ARPE-19 cells (Fig. 1A). Several controls
were performed to determine if this elevation in extracellular ATP was physiological. First, expression of TLR3
and RPE cell marker RPE65 were confirmed using PCR (Fig. 1B; full length gels are included as Supplemental
Information Figure S1A and B). Next, levels of lactate dehydrogenase (LDH) did not increase following stimulation of ARPE-19 cells with poly(I:C), with exposure of 1 or 24 hrs (Fig. 1C). This implied the ATP release accompanying poly(I:C) exposure was not due to a generalized cell lysis. Third, the ability of the luciferin/luciferase
assay to detect ATP levels was not affected by poly(I:C) (Fig. 1D). Fourth, ATP release was confirmed from mouse
RPE cells to ensure the signaling response was also present in primary cells (Fig. 1E, Fig. S1C). Finally, expression
of mRNA for TLR3 and cell marker RPE65 were robust (Fig. 1F) in mouse RPE cells.
To determine whether this released ATP was physiologically relevant, levels of intracellular Ca2+ were monitored in ARPE-19 cells with the indicator Fura-2. Poly(I:C) raised the levels of cytoplasmic Ca2+ in these cells
(Fig. 2A). However, the ectoATPase apyrase produced a significant and reversible reduction in the Ca2+ response
to poly (IC) (Fig. 2B,C). As apyrase can reduce levels of extracellular ATP27, this suggests that released ATP is
involved in the Ca2+ rise induced by poly(I:C).
To examine the contribution of lysosomes to the poly(I:C)-mediated response, the effect of
glycyl-L-phenylalanine 2-naphthylamide (GPN) was tested; the hydrolysis of GPN by lysosomal enzyme
cathepsin C can lead to lysosomal rupture28, with treatment dispersing cellular contents29. Pre-treatment of
RPE cells with GPN abolished the ATP release triggered by poly(I:C) (Fig. 3A). Levels of lysosomal enzyme
acid phosphatase were measured to support the lysosomal association of the released ATP. Poly(I:C) led to
release of acid phosphatase (Fig. 3B). However, pretreatment of cells with GPN also abolished release of acid
phosphatase. Extracellular levels of a second lysosomal enzyme, beta-hexosaminidase, were also elevated after
treatment with poly(I:C) (Fig. 3C). Live-cell imaging in ARPE-19 cells showed overlap between fluorescence
of N-methylanthraniloyl-ATP (MANT-ATP) and the lysosomal marker LysoTracker Red (Fig. 3D), suggesting
concentrated stores of ATP were present in lysosomes.
Additional experiments examined the effect of poly(I:C) on lysosomes. Poly(I:C) led to a small but significant
rise in lysosomal pH (Fig. 4A). The corollary was also true; chloroquine (Fig. 4B) or bafilomycin A1 (Fig. 4C) led
to a release of ATP into the bath similar to that found with poly(I:C). As both drugs can alkalinize lysosomes in
these cells30, these results suggest alkalinization is associated with lysosomal release. The time course of both ATP
(Fig. 4D) and lysosomal enzyme acid phosphatase release (Fig. 4E) were parallel, with extracellular levels increasing with exposure time. The vesicular fusion inhibitor N-ethylmaleimide (NEM) reduced ATP release in RPE
cells following exposure to poly(I:C) (Fig. 4F). As NEM blocked lysosomal release from monocytes20, supporting
vesicular fusion in the ATP release triggered by poly(I:C) here, and ARPE-19 cells expressed abundant levels of
secretory lysosome marker Lamp3 (CD63)31 in vesicle-like structures (Fig. 4G)32. Exposure of cells to poly(I:C)
also led to a modest increase in staining for the luminal epitope of lysosomal protein LAMP1 as compared to
controls (Fig. 4H).

TLR3 stimulation triggers rapid release of ATP and lysosomal enzymes from astrocytes. To
determine whether the efflux was a generalized response to TLR3 stimulation, the ability of poly(I:C) to trigger
release was also examined in astrocytes. The astrocytic identity the of primary cultures isolated from the rat optic
nerve head was confirmed by the presence of astrocyte marker GFAP with PCR (Fig. S1D) and by GFAP-positive
staining using immunohistochemistry (Fig. S1E). Addition of 10 µg/ml poly(I:C) led to a rise in extracellular ATP
surrounding astrocytes (Fig. 5A). In contrast to the epithelial cells, the ATP release peaked at 15 min and levels
declined with prolonged exposure to poly(I:C). Lack of LDH release suggested that the ATP release was not due
to cell lysis (Fig. S1F). The time course of acid phosphatase release after poly(I:C) addition paralleled that of the
ATP release in astrocytes and was also distinct from that seen in RPE cells (Fig. 5B), further supporting a physiological release.
The time course of poly(I:C) delivery to the lysosomes was confirmed microscopically using
fluorescently-tagged poly(I:C) (Fig. 5C). After only 10 min exposure, most of the fluorescent poly(I:C) did not
colocalize with lysosomes and was present in larger amorphous clumps, consistent with its presence on the exterior of the membrane. However, after 20 min, overlap between the fluorescent poly(I:C) and LysoTracker Red
was clearly evident, consistent with delivery of the poly(I:C) to the lysosomes by the point when release of ATP
and acid phosphatase was detected. Overlap was reduced but remained in cells examined 60 min after the initial
presentation of fluorescent poly(I:C).
Lysosomal involvement was also suggested in the TLR3-mediated ATP release from astrocytes. To determine
whether ATP was stored in astrocytic lysosomes, staining patterns of the vesicular nucleotide uptake transporter
(VNUT) and secretory lysosome marker LAMP3 were examined. VNUT was present in discrete clusters that
overlapped with LAMP3 staining in places (Fig. 6A). The release of ATP triggered by poly(I:C) was prevented by
NEM (Fig. 6B); the pannexin blocker probenecid did not affect the ATP release triggered by poly(I:C) in spite of
its ability to prevent stretch-mediated ATP release from these cells (Fig. S1G). Together these results are consistent with ATP storage in secretory lysosomes and release through vesicular fusion, and supports the concurrent
SCieNtifiC Reports | (2018) 8:5726 | DOI:10.1038/s41598-018-23877-3
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Figure 1. TLR3 stimulation triggers ATP release from RPE cells. (A) ATP levels bathing ARPE-19 cells were
increased after 20 min exposure to 10 µg/ml poly(I:C) (PIC) (n = 3 trials of 30 wells). (B) PCR gel of cultured
human ARPE-19 cells showing message for human TLR3 (hTLR3) and RPE-65 (hRPE65); “ + ” with and “−“
without reverse transcriptase. Full gels in Supplemental Figure. (C) Poly(I:C) stimulation of ARPE-19 cells for
1 or 24 hrs did not release lactose dehydrogenase (LDH) into the bath but lysing cells with Triton X did; n = 4,
p < 0.01. (D) ATP standard curve with (red triangles) and without (white circles) 10 µg/ml poly(I:C) show
no effect of the drug on the assay; fit with first order regression, n = 3. (E) Extracellular levels of ATP bathing
mouse RPE cultures (mRPE) after 20 min exposure to 10 µg/ml poly(I:C), n = 18. (F) PCR gel demonstrating
bands for mouse TLR3 (mTLR3) and marker RPE-65 (mRPE65) in primary cultures of mouse RPE. Results
from RPE cells are colored red throughout. Here and throughout the figures, bars represent mean ± SEM.

release of lysosomal acid phosphatase and ATP in response to TLR3 stimulation. To examine whether lysosomal
alkalization contributed to ATP release in astrocytes, the lysosomal pH was determined. Poly(I:C) alkalinized
lysosomes in astrocytes (Fig. 6C). Lysosomal alkalinization by chloroquine (Fig. 6D) or bafilomycin A (Fig. 6E)
was sufficient to induce ATP secretion from astrocytes, as in RPE cells.
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Figure 2. Poly(I:C)-dependent ATP release raises cell calcium. (A) Representative images of ARPE-19 cells
loaded with Ca2+ indicator Fura-2 and excited at 340 nm (em > 540 nm) in control solution (left) and during
application of poly(I:C) (30 µg/ml); brighter signal is consistent with higher cytoplasmic Ca2+ levels. (B)
Representative trace from ARPE-19 cell loaded with Fura-2 showing how addition of poly(I:C) (30 µg/ml)
elevated the Fura-2 ratio (340/380 nm excitation, >540 nm emission) while the ectoATPase apyrase (10 U/
ml) reduced the ratio. (C) Summary of responses in cells exposed to poly(I:C) (PIC) and apyrase (Apy) as in A.
Ratio values normalized to the mean starting ratio in each cell (n = 11, *p < 0.05). Similar responses found in 4
trials.

Figure 3. TLR3 and release of lysosomal ATP. Pretreatment of ARPE-19 cells with 200 µM GPN for 60 min to
rupture lysosomes prevented the release of ATP (A *p = 0.026) and acid phosphatase (B *p = 0.041) detected
upon exposure to 10 µg/ml poly(I:C) (n = 3–6 for both). (C) Exposure to poly(I:C) also increased bath levels of
beta-hexosaminidase (*p = 0.040, n = 23). (D) Staining of fluorescent ATP marker MANT-ATP (green) merged
with LysoTracker (red).

Lysosomal ATP release a general response to TLR3 agonists including scrambled siRNA. While

the preceding data indicate TLR3 agonist poly(I:C) leads to the release of lysosomal ATP, the role of TLR3 was
examined. Levels of phosphorylated TLR3 (Tyr759) were increased by poly(I:C) after only 5 min exposure to
poly(I:C), implicating receptor phosphorylation as an early step in the response (Fig. 7A,B, Fig. S1H). The release
of ATP triggered by poly(I:C) was reduced by inhibiting TANK-binding kinase 1 (TBK-1) with BX-795 (Fig. 7C).
As TBK-1 is activated downstream from TRAM-TRIF33, this strengthens the role of TLR3 and a non-MyD88
pathway in the ATP release triggered by poly (I:C).
Several studies indicate nonspecific siRNA constructs can stimulate TLR3s and trigger responses, with
the length of the nucleotide strand affecting receptor dimerization and the cellular response25,34,35. To determine whether these non-specific nucleotides induced release of lysosomal enzymes and ATP in a similar
size-dependent manner, we synthesized these same 21-nt Luc siRNA and 16-nt Luc siRNA constructs against the
firefly luciferase gene (see Table 1), and tested their effect on the release of ATP. The 21-nt Luc siRNA triggered an
SCieNtifiC Reports | (2018) 8:5726 | DOI:10.1038/s41598-018-23877-3
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Figure 4. Lysosomal alkalinization and vesicular release in RPE cells. (A) Exposure to poly(I:C) produced a
small but significant elevation of lysosomal pH in ARPE-19 cells (n = 4 trials with 20 wells). Raising lysosomal
pH with either 10 µM chloroquine (B CHQ, n = 5 trials of 30 wells) or 8 µM bafilomycin A1 (C BAF, 3 trials with
30 wells) for 20 min led to ATP release. The time-course of ATP release (D) paralleled that of acid phosphatase
release (E) following exposure to 10 µg/ml poly (I:C). Levels are normalized to control ATP/acid phosphatase
levels for each trial (3 trials with 20+wells). *p < 0.05 vs. control, #p < 0.05 vs. poly(I:C) alone. (F) ATP release
from cells exposed to 10 µg/ml poly(I:C) was reduced by 1 mM N-ethylmaleimide (NEM, n > 30). (G) ARPE-19
cells stained for secretory lysosome marker Lamp3 (CD63, magenta) and DAPI (blue). (H) Exposure of cells to
poly(I:C) for 30 min increased staining for the luminal epitope of LAMP1 (green) on the cell surface.

SCieNtifiC Reports | (2018) 8:5726 | DOI:10.1038/s41598-018-23877-3
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Figure 5. TLR3 stimulation triggers ATP release from rat optic nerve head astrocytes. (A) The timedependence of ATP release from astrocytes, with levels recorded at the indicated time after addition of 10 µg/
ml poly(I:C); ATP concentration was normalized to mean control for each trial, n ≥ 30. Results from astrocytes
are colored blue throughout. (B) The release of acid phosphatase in response to poly(I:C) (PIC) followed a
similar rapid time course to the ATP release. *p < 0.05 vs. control, n = 6–10. (C) Colocalization of fluorescent
poly(I:C) (green) and LysoTracker Red at 10, 20 and 60 min after first exposure to fluorescent poly(I:C). Overlap
is indicated by white arrows.

Figure 6. Lysosomal alkalinization and vesicular release in astrocytes. (A) Co-staining for the vesicular
nucleotide uptake transporter (VNUT, red) and LAMP3 (green) in astrocytes, showing overlap in some
locations. (B) The ATP release triggered by poly(I:C) was inhibited by 1 mM NEM (n = 20). (C) Poly(I:C)
(10 µg/ml) raised lysosomal pH in astrocytes (n ≥ 30). Alkalinization of astrocyte lysosomes with chloroquine
(D) CHQ, 10 µM, n ≥ 30) and bafilomycin A1 (E) BAF, 10 ng/ml, n = 30) increased concentration of ATP in the
bath. *p < 0.05 vs. control, #p < 0.05 vs. poly(I:C) alone.

ATP efflux from ARPE-19 cells comparable to the release with poly(I:C), producing a robust release detected after
60 but not 15 min (Fig. 7C). In contrast, the 16-nt Luc siRNA did not induce a significant release. The non-specific
siRNA constructs had an analogous effect on astrocytes, with the 21-nt Luc siRNA, but not the 16-nt Luc siRNA,
leading to ATP release at 15 min (Fig. 7D).
Commercially available “non-targeting” siRNA was examined for its ability to trigger lysosomal release. This
scrambled negative control siRNA is reported to have no similarity to human mouse or rat transcript sequences,
and while the sequence is proprietary the manufacturer confirmed the product was at least 21 nucleotides in
length. This scrambled siRNA led to an release of both ATP (Fig. 7E) and acid phosphatase (Fig. 7F). This suggests
SCieNtifiC Reports | (2018) 8:5726 | DOI:10.1038/s41598-018-23877-3
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Figure 7. TLR3 stimulation. (A) Stimulation of ARPE-19 cells with 10 µg/ml poly(I:C) (PIC) for 5 min
increased levels of phosphor-TLR-3 Tyr759 receptor over control (Cont). Representative immunoblot, showing
increased phosphorylated band after only 5 min. Bands are ~30 kD p-TLR3, ~37 kD GAPDH. Full blot in
Supplemental Fig. 1. (B) Densitometry quantification of increased pTLR3 band size normalized to GAPDH,
(n = 6, p < 0.05). (C) Release of ATP triggered after 30 min in 20 µg/ml poly(I:C) was blocked in astrocytes that
were incubated in 10 µM BX-975 for 6 hrs. (D) ATP release from ARPE-19 cells was stimulated by 21-nt Luc
siRNA (5 µg/ml) but not 16-nt Luc siRNA (5 µg/ml), with an increase after 60 min exposure but not 15 min. The
time course of ATP release induced by the 21-nt Luc siRNA paralleled that of poly(I:C) (10 µg/ml). (E) The ATP
release by 21-nt Luc siRNA but not 16-nt Luc siRNA was also observed in astrocytes (shown in blue, only 15 min
tested). (F) Exposure to commercially available non-targeting scrambled siRNA (Scr siRNA, 5 µg/ml) led to a
release of ATP (n = 20, p < 0.001) and acid phosphatase (G) n = 4, p < 0.001) from ARPE-19 cells at 30 min.

release of lysosomal ATP as a general response of cells to a variety of TLR3 agonists including commercially
available non-specific siRNA. Interestingly, addition of lipopolysaccharide (LPS, 1 µg/ml 0111:B4) for 1 hr also
increased the ATP release from ARPE-19 cells (Fig. S1I).

Role for TRPML1. TRPML1 is a lysosomal cation channel implicated in fusion of lysosomal membranes
with the plasma membrane in exocytosis36. Astrocytes from TRPML1 KO mice were examined to determine
whether the channel contributed to the release of ATP in response to TLR3 stimulation. The release of ATP
from the TRPML1 KO cells was significantly reduced when compared to wild-type cells (Fig. 8A), suggesting
a lysosomal ATP release required TRPML1. We have recently demonstrated that lysosomal signaling is diminished in cells from the TRPML1 KO mouse29. To determine whether activity of TRPML1 was sufficient to trigger lysosomal ATP release, the small molecule ML-SA1 was examined as it activates TRPML channels, and can
SCieNtifiC Reports | (2018) 8:5726 | DOI:10.1038/s41598-018-23877-3
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Gene

Forward primer (5′ to 3′)

Reverse primer (5′ to 3′)

Size (bp)

rTLR3

GATTGGCAAGTTATTCGTC

GCGGAGGCTGTTGTAGG

209

rGFAP

GCCGCTCCTATGCCTCCTCCGA

TCCAGCGACTCAACCTTCCTCT

547

hTRL3

CGGGCCAGCTTTCAGGAACCTG

GGCATGAATTATATATGCTGC

400

hRPE65

GTTTCTGATTGTGGATCTC

GGGATGTTAATCTCCACTTC

603

mTLR3

CAAATCCACTTAAAGAGTTCTCCCCG

CACCAATCCCGTGAAGGTATTGCTT

521

mRPE65

ATGACTGAGAAGAGGATTGTC

CTGCTTTCAGTGGAGGGATC

367

21-nt-siRNA

UAAGGCUAUGAAGAGAUACdTdT

From25

21

16-nt-siRNA

UAAGGCUAUGAAGAdTdT

From25

16

Table 1. Primers used to demonstrate gene expression or sequences to activate TLR3.

Figure 8. Role of TRPML1. (A) The ATP release triggered by PIC in mouse astrocytes was significantly reduced
in astrocytes from the TRPML1 knockout mice. (n = 15, *p < 0.01; **p < 0.05 paired Student’s t-tests). (B)
Levels of ATP released into the bath after addition of 20 µM ML-SA1 to astrocytes (n = 14, 13). (C) Mean levels
of ATP released into the bath surrounding astrocytes 15 min after addition of ML-SA1 (n = 14, 13, p < 0.001).
(D) Mean levels of acid phosphatase in bath surrounding astrocytes 60 min after addition of 20 µM ML-SA1
(n = 8, p = 0.001). (E) Exposure of ARPE-19 cells to 20 µM ML-SA1 for 30 min increased staining for the
luminal epitope of LAMP1 on the cell surface.
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Figure 9. Induction of autophagy and release of lysosomal ATP. (A) Starvation of ARPE-19 cells prevented the
release of ATP by 30 min poly(I:C) (10 µg/ml) ATP levels were normalized to the mean control for each plate
(n ≥ 30), *p < 0.001 vs control. (B) Starvation of astrocytes (blue) prevented the release of ATP accompanying
15 min exposure to 10 µg/ml poly(I:C). *p < 0.001 vs control. (C) Cell starvation prevented acid phosphatase
release in ARPE-19 cells treated with poly(I:C) for 30 min. *p = 0.01 vs control. (D) Exposure of ARPE-19 cells
to 1 µM rapamycin for 24 hrs did not prevent the release of ATP triggered by poly(I:C). (n = 30, *p < 0.0035) (E)
RPE cells isolated from LC3-GFP mice show clusters of LC3 with Torin1. Staining was sometimes observed with
poly(I:C) but this was not always consistent. Control – untreated, Torin – 3 hrs 1 µM Torin1, PIC – 3 hrs 10 µg/
ml poly(I:C), PIC + Torin - combined for 3 hrs.

trigger the release of lysosomal Ca2+, a key step in fusion of lysosomes with other membranes37–39. Exposure of
astrocytes to 20 µM ML-SA1 led to a sustained increased in the level of ATP in the extracellular space (Fig. 8B,C).
ML-SA1 application also led to a significant increase in acid phosphatase into the bath (Fig. 8D). Finally, ML-SA1
increased levels of the luminal epitope of LAMP1 on the surface, consistent with fusion of the lysosomal and
plasma membrane. Together, these findings suggest a role for the TRPML1 channel in the lysosomal ATP release
triggered by TLR3.

Autophagy and lysosomal release. Conditions known to manipulate mTOR were examined for their
impact on lysosomal ATP exocytosis as stimulation of TLR3 activates AKT which in turn activates the mammalian target of rapamycin (mTOR1)40,41. First, the ability of poly(I:C) to trigger ATP release was compared in
cells grown in standard conditions with 10% serum, or in cells starved of serum for 24 hrs. Cell starvation completely prevented the release of ATP in ARPE-19 cells (Fig. 9A). The poly(I:C) triggered release of ATP was also
eliminated in starved astrocytes (Fig. 9B). To determine whether this reflected a specific reaction of starvation
on cellular energetics, levels of acid phosphatase were also measured. Cell starvation also eliminated the rise in
acid phosphatase induced by TLR3 (Fig. 9C). In contrast, a 24 hr treatment with rapamycin had no effect on ATP
release (Fig. 9D) triggered by poly(I:C). RPE cells from LC3-GFP mice were examined to further investigate the
relationship between poly(I:C) and autophagy using the more selective mTOR inhibitor Torin 1 (Fig. 9E). In
control conditions, fluorescence was disperse and at the limits of resolution. Treatment of cells with poly(I:C) for
3 hrs increased particulate fluorescence, with typical cells displaying multiple LC3 puncta indicative of autophagosomes42. Cells exposed to Torin 1 showed particulate fluorescence equal to or often greater that that observed
with poly(I:C). Cells treated with both poly(I:C) and Torin 1 were the same as those treated with Torin1 alone.
This general pattern was observed in three independent trials, suggesting poly(I:C) induced aggregation of LC3
and did not interfere with induction by Torin1.

Discussion

This study suggests that stimulation of TLR3 leads to the efflux of lysosomal enzymes and ATP. The data from rat
optic nerve head astrocytes and from retinal pigmented epithelial cells of human and mouse origin suggests this
link between TLR3 and lysosomal ATP release is a widespread response across species and in cell types traditionally considered non-immune. The ability of several non-specific RNA constructs including poly(I:C), impermeable 21-nt Luc siRNA, and non-targeting scrambled siRNA to induce lysosomal ATP release suggest this response
may be contribute to events under both experimental and endogenous conditions. The ability of released ATP to
raise cell calcium suggests this response may also have physiologic relevance for general cell signaling.
Several observations suggested that the release of ATP triggered by TLR3 receptor activation was lysosomal.
First, lysosomal storage of ATP was supported by the colocalization of VNUT with LAMP3 in fixed cells, and by
SCieNtifiC Reports | (2018) 8:5726 | DOI:10.1038/s41598-018-23877-3
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LysoTracker with MANT-ATP using live cells. Next, the release of lysosomal enzymes acid phosphatase and β
hexosaminidase following treatment with poly(I:C) support lysosomal release; the parallel time courses of ATP
and acid phosphatase release in different cell types provide additional support. The elimination of both ATP and
acid phosphatase release following treatment with GPN also implicates lysosomes, as we recently showed GPN
dramatically reduced the number of functional lysosomes in RPE cells29. Finally, that ability of NEM to inhibit
the ATP release from both the epithelial cells and astrocytes resembles its ability is to block lysosomal ATP release
from monocytes20. The soluble NEM-sensitive factor attachment protein receptor (SNARE) factors Syntaxin 7
and VAMP-7 are required for lysosomal fusion in macrophages43, and release of both ATP and lysosomal enzyme
cathepsin B were dependent upon the SNARE VAMP7 in glial cells44. Together, these observations strongly implicate the lysosomes in the poly(I:C)-dependent release.
The signaling pathways linking TLR3 to lysosomal alkalization and release of ATP are predicted to involve
mTOR. Stimulation of TLR3 leads to TRIF-dependent phosphorylation of AKT40, while AKT enables RHEB
to retain mTOR at the lysosomal membrane45. The ability of TBK1 inhibition with BX-795 to prevent the ATP
release induced by poly(I:C) supports involvement of this pathway. Although mTOR can regulate lysosomal
activity indirectly through TFEB46, mTOR may also regulate vHATPase, and thus lysosomal pH, directly47. In
RPE cells, the crystallin CRYBA1 acidifies lysosomes through direct contact with vHATPase ATP6V0A1 subunit
through a mechanism involving mTOR48. Bafilomycin A1 and chloroquine alkalinize the lysosome through different mechanisms, so their common actions on ATP release, combined with the lysosomal alkalization caused by
poly(I:C), suggest alkalization may itself contribute to lysosomal exocytosis as found elsewhere49. The lysosomal
alkalization was more robust in astrocytes than in RPE cells, and the rise in lysosomal markers in the extracellular
space occurred more rapidly in these cells, consistent with alkalization leading to this release. Whether this pathway contributes to the ATP release by poly(I:C) remains to be determined directly.
The lysosomal cation channel TRPML1 may play a key role in the lysosomal ATP release triggered by TLR3.
Lysosomal alkalization can trigger efflux of Ca2+ from lysosomal lumen to the cytoplasm through theTRPML1
channel50, and data above suggest a role for TRPML1 in the response to TLR3. We have recently demonstrated
that pretreatment of RPE cells with GPN prevents the release of lysosomal Ca2+ by ML-SA129, consistent with the
ability of GPN to prevent the poly(I:C)-dependent release in the present study. This elevated cytoplasmic Ca2+
can in turn activate a synaptotagmin VII-associated fusion of lysosomal and plasma membranes, resulting in lysosomal exocytosis36,51. This provides an outline linking TLR3 stimulation with lysosomal alkalization, release of
lysosomal Ca2+ through TRPML1, and subsequent fusion of the lysosomal membrane with the plasma membrane
resulting in ATP release, although this requires further confirmation.
TLR3s are present on both plasma membranes and lysosomal/endosomal membranes and respond to extracellular and intracellular signals52,53. The ability of unmodified siRNA to trigger the lysosomal ATP efflux implies
the involvement of plasma membrane TLR3s, as the 21-nt Luc sequence used here is unable to cross the plasma
membrane of epithelial or endothelial cells unless conjugated to cholesterol25,34. Likewise, the unmodified scrambled siRNA is not expected to be internalized until after receptor binding. The TLRs undergo dimerization and
phosphorylation upon agonist binding, with the 21-nt Luc siRNA, but not the 16-nt Luc siRNA, sequences used
here shown to induce TLR3 dimerization25. Our study demonstrated TLR3 was phosphorylated at Tyr759 within
5 min, analogous to the early stage phosphorylation at 10 min endothelial cells34. The absence of specific antagonists to TLR3 also make these parallels with 16-nt and 21-nt Luc siRNA useful at implicating the TLR3 receptor.
While the lysosomal ATP efflux triggered by non-targeting scrambled siRNA is consistent with a TLR3 response,
it suggests that extra caution should be given to the interpretation of siRNA experiments related to lysosomes
and autophagy; increased extracellular ATP and lysosomal enzymes, combined with a decrease in lysosomes,
may well accompany even negative controls. This also calls into question the usefulness of treatment paradigms
for pathology that utilize siRNA gene therapy, as expression of dsRNA molecules could activate TLRs and elicit
inflammatory responses. Shifting to shorter siRNA constructs of 16 base pairs is predicted to avoid this side effect
and should be considered, especially in experiments involving autophagy-related questions.
The endogenous ligand for TLR3 in optic nerve head astrocytes and RPE cells remains open to speculation.
TLR3 is classically activated by viral dsRNA, and there is some evidence of viral inflammation as a cause for
secondary glaucoma54. Many cell types have been shown to release nucleic acids in the form of exosomes55,56,
and while no evidence yet exists that suggests exosome-derived RNA can activate TLR3, other TLRs such as
TLR7/8 can be activated by ssRNA57. Thus, the possibility exists that TLR signaling in optic nerve head astrocytes
or RPE cells could be triggered by endogenous signals and not solely by viral infection. The novel link between
the innate immune system, lysosomal efflux and ATP release described here will likely impact multiple systems.
P2Y receptors are present on RPE cells and astrocytes, and can be associated with cytokine secretion and fluid
regulation58–60. Both cell types contain P2X7 receptors, which have been linked to inflammasome activation61. We
propose the induction of lysosomal ATP efflux by TLR3 lies at the crossroads of several innate immune pathways.

Methods

Mouse RPE cell culture.

All animal procedures were approved by the University of Pennsylvania
Institutional Animal Care and Use Committee (IACUC) protocols #803584 and #804588 in compliance with
the Public Health Service Policy on Humane Care and Use of Laboratory Animals. Mice were reared at 5–15 lux
and sacrificed with CO2. Eyes from mice of both sexes were isolated and processed as described61. C57BL/6 J and
LC3-GFP mice were obtained from Jackson Laboratories (Bar Harbor, ME). To obtain RPE cells, intact eyes from
either gender were incubated in 2% dispase and 0.4 mg/ml collagenase IV for 45 min, rinsed and incubated in
growth medium for 20 min (containing Dulbecco’s modified Eagle medium (DMEM) with 1× minimum essential medium + non-essential amino acids, 3 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin and
2.5 mg/ml Fungizone and/or 50 μg/ml gentamicin, plus 10% fetal bovine serum (FBS); all Invitrogen Corp). In
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some experiments, the anterior segments and retinas were removed and the eyecup was rinsed with Versene
(Dow Chemical) and incubated in 0.25% trypsin for 45 min. Cells from 4 eyes were pooled and sheets of RPE cells
were separated from the choroid and triturated to single cells.

Astrocyte culture.

Primary cultures were grown from Long-Evans rat optic nerve head astrocytes
as described1. In brief, rat pups of either gender were sacrificed by P5, and the optic nerve head digested for
1–2 hours with 0.25% trypsin. After washing, cells were grown in DMEM/F12, 10% FBS, 1% penicillin/streptomycin, and 50 ng/ml epidermal growth factor (EGF). Cells were used up to passage 5. Cultures were found to contain
>99% astrocytes, as defined by glial fibrillary acidic protein (GFAP) immunofluorescence staining. Mouse optic
nerve head astrocytes tissue was collected from 3-month-old C57BL/6 J and TRPML1−/− mice of both genders
using a similar protocol but with only 35 min of trypsin incubation. TRPML1−/− mice were obtained from Susan
Slaugerhaupt of Harvard University62; mice were genotyped for TRPML1 as described62.

ARPE-19 cell. ARPE-19 cells (American Tissue Type Collection, Manassas, VA) were grown to confluence in
25 cm2 primary culture flasks in a 1:1 mixture of DMEM/F12 medium with 3 mM L-Glutamine, 100 µg/ml streptomycin and 2.5 mg/ml Fungizone and/or 50 µg/ml gentamicin and 10% fetal bovine serum (all Invitrogen Corp)
except where indicated. Cells were incubated at 37 °C in 5% CO2 and passaged weekly. Cells were typically grown
for 2+ weeks before experiments. Confirmation of RPE cell marker RPE65 was performed.
Polymerase chain reaction.

Total RNA was extracted from rat optic nerve head astrocytes, ARPE-19
cells and mouse RPE/choroid complex using the TRIzol reagent (Invitrogen) as described1,63–65. Random hexamers were used to reverse transcribe 1 μg of total RNA at 37 °C for 120 min using High-Capacity cDNA Reverse
Transcription Kit. Primers were designed in house using Primer 3 software (http://primer3.wi.mit.edu/) (see
Table S1). PCR products were visualized on a 2.0% agarose gel in TAE buffer using ethidium bromide to stain
DNA.

ATP measurement.

ATP was measured as reported before with minor adjustments1,66. Cells were grown
in 96-well plates until 80% confluent, washed, and wells left with 50 µl control isotonic solution containing (in
mM) NaCl 105, KCl 5, HEPES Acid 6, Na HEPES 4, NaHCO3 5, mannitol 60, glucose 5, CaCl2 1.3; pH 7.4. An
additional 50 µl of isotonic control or experimental solution was added with drugs at twice the desired final concentration. Drugs added include poly(I:C), probenecid, NEM, GPN, rapamycin, bafilomycin and chloroquine.
The 21-mer and 16-mer siRNA constructs shown in Table 1 were based on sequences published by Kleinman
et al.25, while the “non-targeting” scrambled RNA was Silencer Negative Control No. 2 siRNA (#AM4613,
ThermoFisher). After exposure for the indicated time, 20 μl of luciferin/luciferase solution was added to each
well. Luminescence was read 10× on Luminoscan (ThermoFisher) with 100 ms integration time per well, and
converted to ATP concentration with a standard curve corrected for any effect of drugs on the assay. Levels from
mouse astrocytes were measured 45 min after drug addition.

®

Lactate dehydrogenase assay.

LDH released into the extracellular solution was measured as an indicator of cell membrane integrity as described3. Briefly, cells in a 96-well plate were exposed to control or poly(I:C)
solutions or lysed with Triton X-100 and the reaction mixture prepared according to manufacturer’s instructions
(Cytotoxicity Detection Kit LDH, Roche Applied Science). Dye absorbance was measured at 490 nm and converted to LDH concentration using LDH standards.

Measurement of lysosomal pH.

Lysosomal pH was measured as described63. In brief cells were grown
in black 96-well plates, rinsed and incubated with 5 µM LysoSensor Yellow/Blue DND 160 (Invitrogen Corp.)
for 3 min followed by 15 min post-incubation. Lysosomal pH was determined from the ratio of light excited at
340 nm vs. 380 nm (>520 nM em) using a plate reader (Thermo Electron Corp.) and calibrated by exposing cells
to 10 μM H+/Na+ ionophore monensin and 20 μM H+/K+ ionophore nigericin in (in mM) 20 MES, 110 KCl and
20 NaCl at pH 4.0–6.0 for 15 min.

Measurement of cytoplasmic Ca2+.

Cytoplasmic Ca2+ was measured as described29. In brief, ARPE19 cells grown on 25 mm glass coverslips were loaded with 10 µM Fura-2 AM (acetoxymethyl ester, #F1221,
ThermoFisher Scientific) with 0.02% pluronic F-127 (#P3000MP, ThermoFisher Scientific) for 45 min at 37 °C.
Cells were then washed, mounted in a perfusion chamber and visualized using a 40 × objective on a Nikon
Diaphot microscope (Nikon, Melville, NY) as described67. Ratiometric measurements were performed by alternating the excitation wavelength from 340 to 380 nm and quantifying emission ≥512 nm with a charge-coupled
device camera (Photon Technologies International, Lawrenceville, NJ). Cells were perfused with isotonic solution
with poly(I:C) ± apyrase washed over the cells. The ImageJ Pseudocolor Look-Up Table “16 colors” was used for
displayed images, but not quantification68.

Beta- hexosaminidase. ARPE-19 cells grown in 24-well plates were bathed with isotonic solution containing poly(I:C) (50 µg/ml) for 1 hr. A 50 µl sample of supernatant was incubated 1:1 with 1 mM p-nitrophenyl
N-acetyl β-D-glucosaminide in 0.1 M of citrate buffer for 1 hr at 37 °C. The reaction was stopped by adding 200 µl
of 0.4 M of glycine (pH = 10.7). For detection, absorbance was measure at 405 nm.
Immunoblots of phosphorylated TLR3.

Approaches are based upon published work69 with the following modifications. ARPE-19 cells were incubated either control or poly(I:C) (10 µg/ml) for 5 min and protein
extracted. 15 µg protein was separated by SDS-PAGE and processed with a primary antibody to Phospho-TLR3
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Tyr759 (1:200; ThermoFisher Scientific; PA5-23120). The membrane was stripped and reprobed with GAPDH
antibody (1:10,000, Cell Signaling; mAb#2118). Blots were visualized using chemiluminescence with a horseradish peroxidase linked 2nd antibody (1:5000; GE Healthcare).

Acid phosphatase release.

Acid phosphatase activity was quantified with colorimetric assay kit following manufacturer’s instructions (Sigma-Aldrich Corp, CS0740). Extracellular samples were mixed with substrate
P-nitrophenyl phosphate (pNPP) and incubated for 30 min at 37 °C, pH = 4.8. The resulting p-Nitrophenol product was detected at 405 nm. Where possible, the same samples were used to measure both acid phosphatase and
ATP.

Microscopy. Cultured rat astrocytes were fixed with 4 °C methanol/acetone (80%/20%) for 20 min, then
blocked with 10% goat serum in a phosphate buffered saline solution (PBS) for 90 min. Rabbit anti-glial fibrillary acidic protein (GFAP, 1:250 dilution, #MAB360, EMD Millipore, Temecula, CA) polyclonal antibody was
added overnight at 4 °C, followed by a goat anti-rabbit IgG Alexa-Fluor 488 secondary antibody (1:500 dilution,
Abcam Inc, Cambridge MA) for 60 min. For Lamp3 staining, ARPE-19 cells were fixed with 4% paraformaldehyde, washed, and incubated with Lamp3 (CD63 mouse monoclonal, 1:200 #MEM 259, Abcam) and then with
anti-mouse secondary (1:500, Abcam). For VNUT localization, astrocytes were fixed in 4% formaldehyde for
15 min, rinsed with Dulbecco’s PBS and permeabilized at in a PBS + 0.1% Triton X-100 for 10 min, then blocked
with 10% goat serum in SuperBlock blocking buffer (#37515, ThermoFisher Scientific) for 60 min. Anti-Vesicular
Nucleotide Transporter (VNUT antibody) (1:1000 dilution, #ABN83, EMD Millipore, Temecula, CA) and
Lamp3 (10 µg/ml concentration, #ab8219, Abcam, Cambridge, MA) primary antibodies were added overnight
at 4 °C, followed by incubation of goat anti- Guinea Pig IgG Alexa-Fluor 568 (1:500 dilution) and anti-mouse
IgG Alexa-Fluor 488 (1:500 dilution) secondary antibodies for 60 min. Slides were mounted in Slow Fade Gold
Antifade Mountant and imaged using a Nikon fluorescent microscope (Eclipse E600). ARPE-19 cells were
incubated with MANT-ATP (10 µM, ex. 360 nm, #M12417) and LysoTracker Red DND99 (50 nM, ex 564 nm
L7528 both ThermoFisher Scientific) for 1 hr at 37 °C. RPE cells from LC3-GFP mice were imaged at 488 nm.
Images were obtained in Nikon A1R confocal microscope system at the University of Pennsylvania Live Cell
Imaging Core with NIS-Elements software or Nikon Eclipse E600 epifluorescent microscope (Nikon Inc.). Poly
(I:C)-fluorescein (ThermoFisher Scientific) was added in medium at 10 µg/ml for indicated time. Cells were then
incubated with 100 nM LysoTracker Red DND-99 for 5 min, fixed with 4% Paraformaldehyde, washed, labeled
with Hoechst and viewed under a Nikon E600 fluorescent microscope. To monitor appearance of lysosomal
lumen protein on the plasma membrane, cells were exposed to poly(I:C), ML-SA1 or control medium for 30 min
with anti-rat monoclonal LAMP1–1DB4 (#ab25245, Abcam Inc.) at 37 °C for 30 min. Cells were washed, fixed
in formaldehyde, then exposed to Alexa-488 conjugated anti–rat secondary antibodies (ThermoFisher Inc.) for
60 min at room temperature. After staining with DAPI, cells were visualized with confocal microscopy as above
and processed with ImageJ68.
Data Analysis.

All data are expressed as mean ± standard error of the mean. Significance was defined as
p < 0.05 and was determined using a one-way ANOVA followed by an appropriate post-Hoc test using SigmaStat
software (Systat Software, Inc., San Jose, CA) unless otherwise noted. On occasions when data were not normally
distributed, analysis was performed on ranks and the Mann-Whitney Rank Sum test was used. ATP/acid phosphatase levels were occasionally normalized to the mean value for each plate or set to account for trial by trial
variation in absolute numbers.
Portions of this work have previously appeared in abstract form70,71.
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Summary Statement. This study identifies crosstalk between the innate immune system, autophagy
and purinergic signaling. Lysosomal exocytosis of ATP is triggered by multiple agonists to TLR3 including
“non-targeting” scrambled siRNA and involves TRPML1.

References

1. Beckel, J. M. et al. Mechanosensitive release of adenosine 5′-triphosphate through pannexin channels and mechanosensitive
upregulation of pannexin channels in optic nerve head astrocytes: a mechanism for purinergic involvement in chronic strain. Glia
62, 1486–1501 (2014).
2. Beckel, J. M. et al. Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder. J Physiol 593, 1857–1871
(2015).
3. Xia, J. et al. Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2X7
receptors. J Physiol 590, 2285–2304 (2012).
4. Beckel, J. M. & Birder, L. A. Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder
epithelium of the rat. J Physiol 590, 1465–1480 (2012).
5. Huang, Y. A. & Roper, S. D. Intracellular Ca(2+) and TRPM5-mediated membrane depolarization produce ATP secretion from taste
receptor cells. J Physiol 588, 2343–2350 (2010).
6. Ren, H. et al. Toll-like receptor-triggered calcium mobilization protects mice against bacterial infection through extracellular ATP
release. Infect Immun 82, 5076–5085 (2014).
7. Orriss, I. R. et al. Hypoxia stimulates vesicular ATP release from rat osteoblasts. J Cell Physiol 220, 155–162 (2009).
8. Ma, Z., Tanis, J. E., Taruno, A. & Foskett, J. K. Calcium homeostasis modulator (CALHM) ion channels. Pflugers Arch 468, 395–403
(2016).
9. Workman, A. D. et al. CALHM1-mediated ATP release and ciliary beat frequency modulation in nasal epithelial cells. Scientific
Reports 7, 6687 (2017).

SCieNtifiC Reports | (2018) 8:5726 | DOI:10.1038/s41598-018-23877-3

12

www.nature.com/scientificreports/
10. Sabirov, R. Z. & Okada, Y. ATP release via anion channels. Purinergic Signal 1, 311–328 (2005).
11. Dahl, G. ATP release through pannexon channels. Philos Trans R Soc Lond B Biol Sci 370 (2015).
12. Reigada, D. et al. Control of neurotransmitter release by an internal gel matrix in synaptic vesicles. Proc Natl Acad Sci USA 100,
3485–3490 (2003).
13. Pankratov, Y., Lalo, U., Verkhratsky, A. & North, R. A. Vesicular release of ATP at central synapses. Pflugers Arch 452, 589–597
(2006).
14. Fitz, J. G. Regulation of cellular ATP release. Trans Am Clin Climatol Assoc 118, 199–208 (2007).
15. Blum, A. E., Joseph, S. M., Przybylski, R. J. & Dubyak, G. R. Rho-family GTPases modulate Ca(2+) -dependent ATP release from
astrocytes. Am J Physiol Cell Physiol 295, C231–241 (2008).
16. Okada, S. F. et al. Inflammation promotes airway epithelial ATP release via calcium-dependent vesicular pathways. Am J Respir Cell
Mol Biol 49, 814–820 (2013).
17. Lalo, U. et al. Exocytosis of ATP from astrocytes modulates phasic and tonic inhibition in the neocortex. PLoS Biol 12, e1001747
(2014).
18. Harada, K., Kamiya, T. & Tsuboi, T. Gliotransmitter release from astrocytes: functional, developmental, and pathological
implications in the brain. Front Neurosci 9, 499 (2015).
19. Zhang, Z. et al. Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell Biol 9, 945–953 (2007).
20. Sivaramakrishnan, V., Bidula, S., Campwala, H., Katikaneni, D. & Fountain, S. J. Constitutive lysosome exocytosis releases ATP and
engages P2Y receptors in human monocytes. J Cell Sci 125, 4567–4575 (2012).
21. Dou, Y. et al. Microglial migration mediated by ATP-induced ATP release from lysosomes. Cell Res 22, 1022–1033 (2012).
22. Settembre, C., Fraldi, A., Medina, D. L. & Ballabio, A. Signals from the lysosome: a control centre for cellular clearance and energy
metabolism. Nat Rev Mol Cell Biol 14, 283–296 (2013).
23. Takeda, K. & Akira, S. Toll-like receptors in innate immunity. Int Immunol 17, 1–14 (2005).
24. Vercammen, E., Staal, J. & Beyaert, R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin
Microbiol Rev 21, 13–25 (2008).
25. Kleinman, M. E. et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452, 591–597 (2008).
26. Roberts, J. S. et al. Opportunistic pathogen porphyromonas gingivalis modulates danger signal ATP-mediated antibacterial NOX2
pathways in primary epithelial cells. Front Cell Infect Microbiol 7, 291 (2017).
27. Albalawi, F. et al. The P2X7 receptor primes IL-1β and the NLRP3 inflammasome in astrocytes exposed to mechanical strain. Front
in Cell Neurosci 11, 227 (2017).
28. Berg, T. O., Stromhaug, E., Lovdal, T., Seglen, O. & Berg, T. Use of glycyl-L-phenylalanine 2-naphthylamide, a lysosome-disrupting
cathepsin C substrate, to distinguish between lysosomes and prelysosomal endocytic vacuoles. Biochem J 300(Pt 1), 229–236 (1994).
29. Gomez, N. M. et al. Robust lysosomal calcium signaling through channel TRPML1 is impaired by lipofuscin accumulation Faseb J
32 (2018).
30. Liu, J. et al. Restoration of lysosomal pH in RPE cells from cultured human and ABCA4(−/−) mice: pharmacologic approaches and
functional recovery. Invest Ophthalmol Vis Sci 49, 772–780 (2008).
31. Blott, E. J. & Griffiths, G. M. Secretory lysosomes. Nat Rev Mol Cell Biol 3, 122–131 (2002).
32. Li, D., Ropert, N., Koulakoff, A., Giaume, C. & Oheim, M. Lysosomes are the major vesicular compartment undergoing
Ca2 + -regulated exocytosis from cortical astrocytes. J Neurosci 28, 7648–7658 (2008).
33. Kawasaki, T. & Kawai, T. Toll-like receptor signaling pathways. Front Immunol 5, 461 (2014).
34. Cho, W. G. et al. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc Natl Acad Sci
USA 106, 7137–7142 (2009).
35. Kleinman, M. E. et al. Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol Ther 20, 101–108 (2012).
36. Samie, M. et al. A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis. Developmental Cell 26,
511–524 (2013).
37. Shen, D. et al. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat
Commun 3, 731 (2012).
38. Feng, X., Xiong, J., Lu, Y., Xia, X. & Zhu, M. X. Differential mechanisms of action of the mucolipin synthetic agonist, ML-SA1, on
insect TRPML and mammalian TRPML1. Cell calcium 56, 446–456 (2014).
39. Cao, Q., Yang, Y., Zhong, X. Z. & Dong, X.-P. The lysosomal Ca2+ release channel TRPML1 regulates lysosome size by activating
calmodulin. J Biol Chem 292, 8424–8435 (2017).
40. Joung, S. M. et al. Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANKbinding kinase 1. J Immunol 186, 499–507 (2011).
41. Jewell, J. L., Russell, R. C. & Guan, K. L. Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 14, 133–139 (2013).
42. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition. Autophagy 12, 1–222
(2016).
43. Ward, D. M., Pevsner, J., Scullion, M. A., Vaughn, M. & Kaplan, J. Syntaxin 7 and VAMP-7 are soluble N-ethylmaleimide-sensitive
factor attachment protein receptors required for late endosome-lysosome and homotypic lysosome fusion in alveolar macrophages.
Mol Biol Cell 11, 2327–2333 (2000).
44. Verderio, C. et al. TI-VAMP/VAMP7 is the SNARE of secretory lysosomes contributing to ATP secretion from astrocytes. Biol Cell
104, 213–228 (2012).
45. Puertollano, R. mTOR and lysosome regulation. F1000Prime Rep 6, 52 (2014).
46. Settembre, C. et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J
31, 1095–1108 (2012).
47. Liberman, R., Bond, S., Shainheit, M. G., Stadecker, M. J. & Forgac, M. Regulated assembly of vacuolar ATPase is increased during
cluster disruption-induced maturation of dendritic cells through a phosphatidylinositol 3-kinase/mTOR-dependent pathway. J Biol
Chem 289, 1355–1363 (2014).
48. Valapala, M. et al. Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/betaA3/A1crystallin via V-ATPase-MTORC1 signaling. Autophagy 10, 480–496 (2014).
49. Sundler, R. Lysosomal and cytosolic pH as regulators of exocytosis in mouse macrophages. Acta Physiol Scand 161, 553–556 (1997).
50. Lee, J.-H. et al. Ralph A. Presenilin 1 maintains lysosomal Ca2+ homeostasis via TRPML1 by regulating vATPase-mediated
lysosome acidification. Cell Reports 12, 1430–1444 (2015).
51. Xu, H. & Ren, D. Lysosomal physiology. Annu Rev Physiol 77, 57–80 (2015).
52. Pohar, J., Pirher, N., Bencina, M., Mancek-Keber, M. & Jerala, R. The ectodomain of TLR3 receptor is required for its plasma
membrane translocation. PLoS One 9, e92391 (2014).
53. Amarante, M. K. & Watanabe, M. A. Toll-like receptor 3: involvement with exogenous and endogenous RNA. Int Rev Immunol 29,
557–573 (2010).
54. Merayo-Lloves, J., Power, W. J., Rodriguez, A., Pedroza-Seres, M. & Foster, C. S. Secondary glaucoma in patients with uveitis.
Ophthalmologica 213, 300–304 (1999).
55. Lafourcade, C., Ramírez, J. P., Luarte, A., Fernández, A. & Wyneken, U. MiRNAs in astrocyte-derived exosomes as possible
mediators of neuronal plasticity. J Exp Neurosci 10, 1–9 (2016).

SCieNtifiC Reports | (2018) 8:5726 | DOI:10.1038/s41598-018-23877-3

13

www.nature.com/scientificreports/
56. Zhang, J. et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics, Proteomics & Bioinformatics 13,
17–24 (2015).
57. Haderk, F. et al. CLL Exosome-derived Y RNA hY4 induces TLR7/8-mediated inflammation and PD-L1 expression in monocytes.
Blood 128, 3217 (2016).
58. Mitchell, C. H. & Reigada, D. Purinergic signalling in the subretinal space: a role in the communication between the retina and the
RPE. Purinergic Signal 4, 101–107 (2008).
59. James, G. & Butt, A. M. P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ. Cell
Calcium 30, 251–259 (2001).
60. Sanderson, J. et al. Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal
neurons, astrocytes, Muller cells, lens, trabecular meshwork, cornea and lacrimal gland. Exp Eye Res 127, 270–279 (2014).
61. Guha, S. et al. Lysosomal alkalinization, lipid oxidation, and reduced phagosome clearance triggered by activation of the P2X7
receptor. FASEB J 27, 4500–4509 (2013).
62. Venugopal, B. et al. Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Am J Hum
Genet 81, 1070–1083 (2007).
63. Guha, S. et al. Approaches for detecting lysosomal alkalinization and impaired degradation in fresh and cultured RPE cells: evidence
for a role in retinal degenerations. Exp Eye Res 126, 68–76 (2014).
64. Reigada, D., Lu, W. & Mitchell, C. H. Glutamate acts at NMDA receptors on fresh bovine and on cultured human retinal pigment
epithelial cells to trigger release of ATP. J Physiol 575, 707–720 (2006).
65. Liu, J. et al. Cystic fibrosis transmembrane conductance regulator (CFTR) contributes to reacidification of alkalinized lysosomes in
RPE cells. Am J Physiol Cell Physiol 303, C160–169 (2012).
66. Reigada, D. & Mitchell, C. H. Release of ATP from retinal pigment epithelial cells involves both CFTR and vesicular transport. Am
J Physiol Cell Physiol 288, C132–140 (2005).
67. Zeiger, U., Mitchell, C. H. & Khurana, T. S. Superior calcium homeostasis of extraocular muscles. Exp Eye Res 91, 613–622 (2010).
68. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9, 671–675 (2012).
69. Lu, W. et al. Rat, mouse and primate models of chronic glaucoma show sustained elevation of extracellular ATP and altered
purinergic signaling in the posterior eye. Invest Ophthalmol Vis Sci 56, 3075–3083 (2015).
70. Mitchell, C. H., Beckel, J. M., Lu, W., Lim, J. & Laties, A. M. TLR3 stimulation leads to ATP release from both RPE cells and optic
nerve head astrocytes; a common pathway to escalate the inflammatory response in ocular cells? Invest Ophthalmol Vis Sci 55, 6344
(2014).
71. Mitchell, C. H. et al. TLR3 stimulation leads to ATP release through lysosomal exocytosis from optic nerve head astrocytes and RPE
cells. Invest Ophthalmol Vis Sci 56, 2373 ARVO E-Abstract (2015).

Acknowledgements

The authors would like to thank Dana Graves for the use of his spectrophotometer, Mickey Marks for assistance
with TLR3 signaling and Susan Slaugenhaupt for the use of the TRPML1 knockout mice. This work is supported
by grants from the NIH EY015537(CHM), EY013434 (CHM), EY10420 (KBB), DK106115 (JMB) DK114492
(JMB), core grant EY001583 (CHM, KBB) and the Jody Sack Fund (WL).

Author Contributions

J.M.B.: performed experiments or data analysis, developed the concepts or approach and prepared or edited the
manuscript, N.M.G.: performed experiments or data analysis, developed the concepts or approach and prepared
or edited the manuscript, J.C.L.: performed experiments or data analysis, B.N.: performed experiments or data
analysis, W.L.: performed experiments or data analysis, F.A.: performed experiments or data analysis, K.E.C.:
performed experiments or data analysis, K.B.B.: prepared or edited the manuscript,C.H.M.: developed the
concepts or approach and prepared or edited the manuscript.

Additional Information

Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-23877-3.
Competing Interests: The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
© The Author(s) 2018

SCieNtifiC Reports | (2018) 8:5726 | DOI:10.1038/s41598-018-23877-3

14

